| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/22/2009 | US20090023758 Macrocyclic Inhibitors of Hepatitis C Virus |
| 01/22/2009 | US20090023739 Capase inhibitors and uses thereof |
| 01/22/2009 | US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections |
| 01/22/2009 | US20090023722 Amide substituted imidazoquinolines |
| 01/22/2009 | US20090023720 2-Amino 1H-Imidazo Ring Systems and Methods |
| 01/22/2009 | US20090023676 RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA) |
| 01/22/2009 | US20090023675 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA) |
| 01/22/2009 | US20090023669 Antibacterial Agents |
| 01/22/2009 | US20090023665 Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof |
| 01/22/2009 | US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections |
| 01/22/2009 | US20090023642 Isolation, Purification, and Structure Elucidation of the Antiproliferative Compound Coibamide A |
| 01/22/2009 | US20090023641 Cyclic Antimicrobial Peptides |
| 01/22/2009 | US20090023639 Methods of Treatment |
| 01/22/2009 | US20090023635 Factor VII or VIIa - Like Molecules |
| 01/22/2009 | US20090023224 Vascular endothelial growth factor 2 |
| 01/22/2009 | US20090023216 Double-Stranded Oligonucleotides |
| 01/22/2009 | US20090022815 Halogenated composition, method for preparing same and uses thereof |
| 01/22/2009 | US20090022783 siRNA MICROBICIDES FOR PREVENTING AND TREATING DISEASES |
| 01/22/2009 | US20090022782 Blood Retainable Device Exhibiting Selective Degradability in Tumor Tissue |
| 01/22/2009 | US20090022781 Delivery means |
| 01/22/2009 | US20090022760 Alphavirus Replicon Particles Matched to Protein Antigens as Immunological Adjuvants |
| 01/22/2009 | US20090022759 Adenovirus vector and method to manipulate the adenovirus genome |
| 01/22/2009 | US20090022756 Recombinant F1-V Plague Vaccine |
| 01/22/2009 | US20090022755 Vaccines against chlamydial infection |
| 01/22/2009 | US20090022754 Construction of recombinant immunodominant Rickettsia typhi proteins; using methylated or unmethylated recombinant OmpB fragments in immunoassays for detection of exposure to Rickettsia typhi |
| 01/22/2009 | US20090022753 Surface proteins of streptococcus pyogenes |
| 01/22/2009 | US20090022752 Recovering the protein expressed by open reading frame 2 from porcine circovirus type 2; provide immunogenic composition that comprises PCV2 ORF2 proteins and that are highly stable over a period of 24 months; lung lesions, nasal shedding, cough, diarrhea, |
| 01/22/2009 | US20090022749 Recovering the protein expressed by open reading frame 2 from porcine circovirus type 2; provide immunogenic composition that comprises PCV2 ORF2 proteins and that are highly stable over a period of 24 months |
| 01/22/2009 | US20090022748 Unique associated Kaposi's sarcoma virus sequences and uses thereof |
| 01/22/2009 | US20090022743 Peptides Effective in the Treatment of Tumors and Other Conditions Requiring the Removal or Destruction of Cells |
| 01/22/2009 | US20090022742 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 01/22/2009 | US20090022736 Monoclonal Antibodies That Specifically Bind To And Neutralize Bacillus Anthracis Toxin, Compositions, And Methods Of Use |
| 01/22/2009 | US20090022735 Receptor Binding Polypeptides |
| 01/22/2009 | US20090022733 Methods for treating Disease with an IL-1R antibody |
| 01/22/2009 | US20090022724 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 01/22/2009 | US20090022721 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 01/22/2009 | US20090022720 Conjugate of an antibody against CD4 and antifusogenic peptides |
| 01/22/2009 | US20090022712 Compositions and Methods for Inhibiting Leukocyte Function |
| 01/22/2009 | US20090022709 Control of sorbose utilization genes and uses thereof |
| 01/22/2009 | US20090022707 contacting target cells with a therapeutic quantity of a soluble antibody that specifically binds tumor necrosis factor-related apoptosis inducing ligand receptor(TRAIL) DR5, and contacting target cells with a therapeutic agent |
| 01/22/2009 | US20090022690 Bacterial translocation inhibitor and method of inhibiting bacterial translocation |
| 01/22/2009 | US20090022689 C4-spiro-pyrrolidine antivirals |
| 01/22/2009 | US20090022685 Orthotopic, controllable, and genetically tractable non-human animal model for cancer |
| 01/22/2009 | US20090022669 Compositions for protein delivery via the pulmonary route |
| 01/22/2009 | US20090022663 Antibodies and related molecules that bind to 161p2f10b proteins |
| 01/22/2009 | US20090022656 Lipidated glycoprotein particles and methods of use |
| 01/22/2009 | DE102007033445A1 Diaphragmalyse-Verfahren und Verwendung der nach dem Verfahren erhaltenen Produkte Diaphragmalysis method and use of the products obtained by the process |
| 01/22/2009 | DE102007032799A1 New sugar-containing polypyridine metal complexes e.g. useful as fluorescence markers in biological systems or for treating abnormal cells |
| 01/22/2009 | CA2729011A1 Varicella zoster virus-virus like particles (vlps) and antigens |
| 01/22/2009 | CA2699971A1 Spiro condensed barbituric acid derivatives for use as antibacterial |
| 01/22/2009 | CA2696437A1 Production and use of epitope-tagged hepatitis c virus particle |
| 01/22/2009 | CA2693956A1 Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant |
| 01/22/2009 | CA2693936A1 Conjugate purification |
| 01/22/2009 | CA2693793A1 Anti-viral compounds, compositions, and methods of use |
| 01/22/2009 | CA2693537A1 Macrocyclic indole derivatives for the treatment of hepatitis c infections |
| 01/22/2009 | CA2693533A1 Macrocyclic indole derivatives for the treatment of hepatitis c infections |
| 01/22/2009 | CA2693137A1 Engineered scfv against bovine herpes virus type i |
| 01/22/2009 | CA2693088A1 New antimicrobial compounds, their synthesis and their use for treatment of mammalian infections |
| 01/22/2009 | CA2693051A1 Lantibiotic-based compounds having antimicrobial activity |
| 01/22/2009 | CA2693047A1 The use of type-b lantibiotic-based compounds having antimicrobial activity |
| 01/21/2009 | EP2017337A1 Human tumor necrosis factor receptors |
| 01/21/2009 | EP2017285A1 Antimicrobial linear peptides |
| 01/21/2009 | EP2017281A1 Toll-like receptor 9 agonists |
| 01/21/2009 | EP2017269A2 A pharmaceutical compodition comprising form II crystalline Ritonavir and a preparation thereof |
| 01/21/2009 | EP2016948A2 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 01/21/2009 | EP2016942A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 01/21/2009 | EP2016081A1 Anti-viral pyrimidine nucleoside derivatives |
| 01/21/2009 | EP2016062A2 Anti-viral agents that activate rnase l |
| 01/21/2009 | EP2015759A2 Combination therapy |
| 01/21/2009 | EP2015753A2 Inhibition of hiv infection through chemoprophylaxis |
| 01/21/2009 | EP2015746A2 Use of substituted glycerin derivatives for producing a pharmaceutical preparation |
| 01/21/2009 | EP1487273B1 Compositions and methods for treatment of microbial infections |
| 01/21/2009 | EP1465491B1 Antiseptic compositions and methods |
| 01/21/2009 | EP1399563B1 Moraxella (branhamella) catarrhalis antigens |
| 01/21/2009 | EP1353691B1 Molecular antigen array presenting amyloid beta |
| 01/21/2009 | EP1127107B1 Methods for the production of tcr gamma delta t cells |
| 01/21/2009 | EP1007546B1 Molecular mimetics of meningococcal b epitopes |
| 01/21/2009 | CN101351554A Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 01/21/2009 | CN101351471A Preparation of a crystalline antibiotic substance |
| 01/21/2009 | CN101351452A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 01/21/2009 | CN101351231A Small interfering ribonucleic acid duplexes comprising arabinose modified nucleotides |
| 01/21/2009 | CN101351221A Outer coat protein PA5158 of pseudomonas aeruginosa |
| 01/21/2009 | CN101351218A Method and use of interferon compositions for the treatment of avian influenza |
| 01/21/2009 | CN101351211A Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases |
| 01/21/2009 | CN101351206A Therapeutic agent for liver disease and hepatic function- |
| 01/21/2009 | CN101351204A Novel arylamidine derivative, salt thereof and antifungal agent containing those |
| 01/21/2009 | CN101348799A Construction method and pharmaceutical use of microRNA adenovirus expression plasmid for severe hepatitis related gene hfg12, hFas and hTNFR1 |
| 01/21/2009 | CN101348494A High-purity cefmenoxime hydrochloride and preparation thereof |
| 01/21/2009 | CN101348493A High-purity medicament and preparation thereof |
| 01/21/2009 | CN101348492A High-purity ceftizoxime sodium and preparation thereof |
| 01/21/2009 | CN101348486A Preparation of meropenem |
| 01/21/2009 | CN101348460A Substituted furan (pyridine, pyrazole) formamide tertiary butyl thiacetic mulin ester |
| 01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
| 01/21/2009 | CN101347623A Multifunctional nanodevice platform |
| 01/21/2009 | CN101347611A Medicine bag for treating beriberi |
| 01/21/2009 | CN101347604A Uses of plants from genera Cynoglossum of family Boraginaceae and extract thereof in preparing medicament for treating AIDS |
| 01/21/2009 | CN101347603A Medicament for treating AIDS and method for preparing the same |
| 01/21/2009 | CN101347596A External-use plaster for treating beriberi |
| 01/21/2009 | CN101347586A Chinese herbal medicine additive agent of feed for nursing piglet and method of use thereof |
| 01/21/2009 | CN101347554A Chinese medicine for treating zoster |